Clinical significance of HER2 overexpression as assessed by immunohistochemistry and fluorescence in situ hybridisation in patients with gastric cancer

被引：0
|
作者：
Im, S. [1 ]
Kim, J. [1 ]
Kim, M. [1 ]
Jordan, B. [2 ]
Oh, D. [1 ]
Lee, H. [1 ]
Yang, H. [1 ]
Kim, V [1 ]
Kim, W. [1 ]
Bang, Y. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea
[2] Roche Diagnost Ltd, Rotkreuz, Switzerland
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [31] Correlation between HER2/NEU protein overexpression on immunohistochemistry and flourescence in situ hybridisation in breast carcinoma: problems in a developing country
    Mamoon, N.
    Yaqoob, Z.
    Mudassir, G.
    VIRCHOWS ARCHIV, 2020, 477 : S51 - S51
  • [32] Correlation between HER2 gene amplification and protein overexpression through fluorescence in situ hybridization and immunohistochemistry in breast carcinoma patients
    Makroo, R. N.
    Chowdhry, Mohit
    Kumar, Manoj
    Srivastava, Priyanka
    Tyagi, Richa
    Bhadauria, Preeti
    Kaul, Sumaid
    Sarin, Ramesh
    Das, P. K.
    Dua, Harsh
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (04) : 481 - 484
  • [33] Concordance between immunohistochemistry and fluorescence in situ hybridization for assessment of the HER2
    Cho, S. H.
    Lee, M. R.
    Kim, D. C.
    Lee, K. C.
    Lee, J. H.
    Kwon, H. C.
    Lee, H. S.
    Lee, S.
    BREAST, 2011, 20 : S21 - S21
  • [34] HER2 status of gastric and gastroesophageal cancer (GC) patients assessed by immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and high-resolution array comparative genomic hybridization (aCGH)
    Janjigian, Y. Y.
    Barbashina, V. V.
    Kelsen, D. P.
    Tang, L. H.
    Ilson, D.
    Tafe, L. J.
    Hicks, J. B.
    Shah, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Evaluation of serum HER2 extracellular domain in in metastatic gastric or gastroesophageal junction cancer: Correlation with HER2 status by immunohistochemistry and fluorescence in situ hybridization and clinicopathologic parameters
    An, Xin
    Dai, Shuqin
    Wang, Fang
    Shao, Qiong
    Chen, Cui
    Chen, Yongchang
    Kong, Yanan
    Li, Cong
    Luo, Huiyan
    Liang, Ying
    Wang, Feng-Hua
    Xu, Rui-hua
    Li, Yu-hong
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] SERUM HER2 EXTRACELLULAR DOMAIN LEVELS AND TISSUE HER2 OVEREXPRESSION IN ADVANCED GASTRIC CANCER PATIENTS
    Takahashi, Y.
    Ohori, H.
    Takahashi, M.
    Gamoh, M.
    ANNALS OF ONCOLOGY, 2013, 24 : 32 - 32
  • [37] HER2 Gene Amplification by Fluorescence In Situ Hybridization (FISH) Compared With Immunohistochemistry (IHC) in 122 Equivocal Gastric Cancer Cases
    Liu, Xiaoyan
    Wang, Xiaoling
    Wang, Bo
    Ren, Guoping
    Ding, Wei
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (07) : 459 - 464
  • [38] Concordance of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Using Tissue Microarray in Breast Cancer
    Furrer, Daniela
    Jacob, Simon
    Caron, Chantal
    Sanschagrin, Francois
    Provencher, Louise
    Diorio, Caroline
    ANTICANCER RESEARCH, 2017, 37 (06) : 3323 - 3329
  • [39] Her2 amplification - Correlation of chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization
    Wixom, CR
    Albers, EA
    Weidner, N
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2004, 12 (03) : 248 - 251
  • [40] Testing Wisely: When is Both HER2 Immunohistochemistry and In-Situ Hybridisation Really Necessary?
    Balasubramanian, Adithya
    McDonald, Abi
    Ireland-Jenkin, Kerryn
    Leong, Trishe
    Khor, Richard
    Thursfield, Victoria
    Yeo, Belinda
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 85 - 85
12345